Rua Bioscience Limited — Share Issue/Capital Change 2022

Dec 21, 2022

Capital Change Notice

==> picture [101 x 49] intentionally omitted <==

	Section 1: Issuer information	Section 1: Issuer information	Section 1: Issuer information
	Name of issuer			Rua Bioscience Limited
	NZX ticker code			RUA
	Class of financial product			Ordinary shares
	ISIN (If unknown, check on NZX website)
	Currency			NZD
	Section 2: Capital change details
	Number issue~~d~~		~~/acquired/redeemed~~	8,140,000
	Nominal value		(if any)	N/A
	Issue/acquisition/redemption price per security			N/A
	Nature of the payment (for example, cash or other consideration)			Conversion of performance shares
	Amount paid up (if not in full)			Paid in full
	Percentage of total class of Financial Products issued/~~acquired/redeemed/~~(calculated on the number of Financial Products of the Class, excluding any Treasury Stock, in existence)1			4.90%
	For an issue of Convertible Financial Products or Options, the principal terms of Conversion (for example the Conversion price and Conversion date and the ranking of the Financial Product in relation to other Classes of Financial Product) or the Option (for example, the exercise price and exercise date)			N/A
	Reason	for issu~~e~~		Conversion of performance shares
	for issu~~e~~
	Total number of Financial Products of the Class after the ~~issue/acquisition/redemption/~~Conversion (excluding Treasury Stock) and the total number of Financial Products of the Class held as Treasury Stock after the issu~~e/acquisition/redemption.~~			174,299,267
	held as Treasury Stock after the issu~~e~~
	In the case of an acquisition of shares, whether those shares are to be held as treasury stock			N/A
	Specific authority for the issue, acquisition, or redemption, including a reference to the rule pursuant to which the issue, acquisition, or redemption is made			Listing rule 4.9.1(b)
	Terms or details of the issue, acquisition, or redemption (for example: restrictions, escrow arrangements)			N/A

1 The percentage is to be calculated immediately before the issue, acquisition, redemption or Conversion.

Date of issue/acquisition/redemption2	21/12/2022
Section 3: Authority for this announcement and contact person
Name of person authorised to make this announcement	Hamish White
Contact person for this announcement	Hamish White
Contact phone number
Contact email address	Hamish.white@ruabio.com
Date of release through MAP	21/12/2022

2 Continuous issuers using this form in reliance on Rule 3.13.2, please indicate the period during which the relevant issue/acquisition/redemptions were made (for example, 1 January 2019 to 31 January 2019).